15 January 2014Biotech

Potter Clarkson announces changes at the top

UK law firm Potter Clarkson LLP has made changes to its team with the appointment of two senior managers.

The Nottingham-based firm, which specialises in patents and trademarks, has announced that Colin Baker will be its new managing partner.

Baker (below left), who focuses on the patenting of chemical inventions, has been a partner at the firm since 1999.

He has experience of proceedings before the European Patent Office Opposition Division and Boards of Appeal and has handled more than 100 cases.

Alongside Baker, Andrew Argyle has joined the firm as its new practice director.

Argyle (below right) focuses on commercial and civil litigation and previously worked as a partner at Shakespeares for 15 years.

"This change has been planned and rehearsed for several months," said Baker.

"The change will be seamless and is part of the evolution of our top tier firm which achieves its 125-year milestone this year."

Potter Clarkson LLP advises its clients on IP rights in fields including biotechnology, chemistry, engineering and computing.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotech
17 November 2026   A US judge tosses an antitrust lawsuit accusing Alexion of using sham patent litigation to delay competition to Soliris, finding that its favourable settlement with a rival undermined the claims.
Biotech
16 November 2026   The Swiss pharma giant will work with a Taiwan-based biotech’s ADC platform technologies to develop next-generation cancer therapies in a deal worth potentially more than $2bn, including $30m upfront.
Biotech
13 November 2026   Curiox claims confidential information shared during talks about a potential business partnership was used to develop a competing cell preparation system within months, despite the South Korean company spending years developing its own technology.